Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$738.64 11.43 (1.57%) as of 4:30 Mon 9/8


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 706.57(B)
Last Volume: 4,533,471 Avg Vol: 3,368,842
52 Week Range: $625.65 - $935.02
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    : 19.5
Insider 6 Months    : 19.5
Insider 3/6 Months : 38.1
Guru Rank Number :  412
Guru Rank Value     : 5.2
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 6,987 6,987 6,987 6,987
Total Buy Value $4,537,301 $4,537,301 $4,537,301 $4,537,301
Total People Bought 8 8 8 8
Total Buy Transactions 8 8 8 8
Total Shares Sold 282,250 285,500 1,166,400 4,462,127
Total Sell Value $226,937,952 $229,409,152 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 3 6 16 61
End Date 2025-06-08 2025-03-07 2024-09-06 2023-09-07

   
Records found: 1439
  Page 1 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hernandez Edgardo EVP & Pres., Mfg. Operations   •       –      –    2025-09-05 4 GD $0.00 $0 D/D 17 39,731     -
   Zakrowski Donald A SVP, Finance, & CAO   •       –      –    2025-08-28 4 AS $734.93 $734,930 D/D (1,000) 3,840 -1%     
   Fyrwald J Erik Director   –       •      –    2025-08-18 4 A $698.05 $9,916 D/D 14 74,592     -
   Hedley Mary Lynne Director   –       •      –    2025-08-18 4 A $698.05 $9,916 D/D 14 1,987     -
   Greene Gabrielle E Director   –       •      –    2025-08-18 4 A $698.05 $4,958 D/D 7 2,710     -
   Luciano Juan R Director   –       •      –    2025-08-18 4 A $698.05 $14,834 D/D 21 16,403     -
   Alvarez Ralph Director   –       •      –    2025-08-18 4 A $698.05 $11,750 D/D 17 55,011     -
   Montarce Lucas EVP & CFO   •       –      –    2025-08-15 4 B $691.79 $494,627 D/D 715 14,685 2.74 4%     
   Van Naarden Jacob EVP & Pres., Lilly Oncology   •       –      –    2025-08-13 4 B $647.36 $647,360 D/D 1,000 20,562 2.74 10%     
   Alvarez Ralph Director   –       •      –    2025-08-13 4 B $660.25 $500,473 I/I 758 758 2.1 10%     
   Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm   •       –      –    2025-08-12 4 B $634.41 $634,405 D/D 1,000 137,660 2.74 14%     
   Ricks David A President, Chair, and CEO   •       •      –    2025-08-12 4 B $644.77 $1,052,263 D/D 1,632 546,601 2.81 14%     
   Fyrwald J Erik Director   –       •      –    2025-08-12 4 B $642.00 $1,005,242 D/D 1,565 74,578 2.39 14%     
   Greene Gabrielle E Director   –       •      –    2025-08-12 4 B $641.18 $75,018 D/D 117 2,703 2.39 14%     
   Yuffa Ilya EVP&Pres, LLY USA&Global Capab   •       –      –    2025-08-11 4 AS $627.01 $783,763 D/D (1,250) 26,260 14%     
   Jackson Jamere Director   –       •      –    2025-08-08 4 B $639.56 $127,913 D/D 200 9,402 2.39 16%     
   Seymour Melissa EVP, Global Quality   •       –      –    2025-08-01 4 D $740.07 $315,951 D/D (427) 525     -
   Seymour Melissa EVP, Global Quality   •       –      –    2025-08-01 4 OE $0.00 $0 D/D 952 952     -
   Lilly Endowment Inc   –       –       •   2025-07-24 4 S $803.48 $225,419,259 D/D (280,000) 95,736,978 10%     
   Luciano Juan R Director   –       •      –    2025-07-21 4 A $762.18 $14,834 D/D 19 16,382     -
   Fyrwald J Erik Director   –       •      –    2025-07-21 4 A $762.18 $9,917 D/D 13 73,013     -
   Hedley Mary Lynne Director   –       •      –    2025-07-21 4 A $762.18 $9,917 D/D 13 1,973     -
   Alvarez Ralph Director   –       •      –    2025-07-21 4 A $762.18 $11,750 D/D 15 54,995     -
   Greene Gabrielle E Director   –       •      –    2025-07-21 4 A $762.18 $4,958 D/D 7 2,586     -
   Luciano Juan R Director   –       •      –    2025-06-16 4 A $807.58 $14,834 D/D 18 16,362     -
  1439 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us